Clinical Trials

21 studies in Oncology in Minnesota

  1. A Phase II/III Randomized Trial of Two Doses of MK-3475 (SCH900475) Versus Docetaxel in Previously Treated Subjects With Non-Small Cell Lung Cancer
    1. Minnesota
  2. Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
    1. Minnesota
  3. A Randomized, Double-Blind Pilot Study of N-acetylcysteine Mucoadherent Rinse Versus Placebo for Thickened Secretions and Mucositis Secondary to Chemoradiotherapy in the Management of Head and Neck Malignancies
    1. Arizona,
    2. Minnesota
  4. Evaluating the Impact of 18F-DOPA-PET on Radiotherapy Planning for Newly Diagnosed Gliomas
    1. Minnesota
  5. A Pilot Study Evaluating the Utility of 18F-DOPA PET for Radiotherapy Treatment Planning of Malignant Glioma Patients
    1. Minnesota
  6. Randomized Phase II Study Comparing the MET Inhibitor Cabozantinib to Temozolomide/Dacarbazine in Ocular Melanoma
    1. Minnesota
  7. A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
    1. Minnesota
  8. A Phase I Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma
    1. Arizona,
    2. Minnesota
  9. A Phase 1, Open-label, Dose Escalation, Safety and Tolerability Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies
    1. Florida,
    2. Minnesota
  10. Sympathetic Nerve Activity and Vascular Function in Women With Uterine Leiomyomata
    1. Minnesota
  1. Prev
  2. 1
  3. 2
  4. 3
  5. Next